Cargando…
Editorial Comment to Successful pembrolizumab treatment in a patient with metastatic urothelial carcinoma and underlying overlap syndrome involving systemic sclerosis and systemic lupus erythematosus
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7469765/ https://www.ncbi.nlm.nih.gov/pubmed/32914069 http://dx.doi.org/10.1002/iju5.12193 |
| _version_ | 1783578460386492416 |
|---|---|
| author | Hatakeyama, Shingo Ohyama, Chikara |
| author_facet | Hatakeyama, Shingo Ohyama, Chikara |
| author_sort | Hatakeyama, Shingo |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7469765 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-74697652020-09-09 Editorial Comment to Successful pembrolizumab treatment in a patient with metastatic urothelial carcinoma and underlying overlap syndrome involving systemic sclerosis and systemic lupus erythematosus Hatakeyama, Shingo Ohyama, Chikara IJU Case Rep Editorial Comment John Wiley and Sons Inc. 2020-07-07 /pmc/articles/PMC7469765/ /pubmed/32914069 http://dx.doi.org/10.1002/iju5.12193 Text en © 2020 The Authors. IJU Case Reports published by John Wiley & Sons Australia, Ltd on behalf of the Japanese Urological Association This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| spellingShingle | Editorial Comment Hatakeyama, Shingo Ohyama, Chikara Editorial Comment to Successful pembrolizumab treatment in a patient with metastatic urothelial carcinoma and underlying overlap syndrome involving systemic sclerosis and systemic lupus erythematosus |
| title | Editorial Comment to Successful pembrolizumab treatment in a patient with metastatic urothelial carcinoma and underlying overlap syndrome involving systemic sclerosis and systemic lupus erythematosus |
| title_full | Editorial Comment to Successful pembrolizumab treatment in a patient with metastatic urothelial carcinoma and underlying overlap syndrome involving systemic sclerosis and systemic lupus erythematosus |
| title_fullStr | Editorial Comment to Successful pembrolizumab treatment in a patient with metastatic urothelial carcinoma and underlying overlap syndrome involving systemic sclerosis and systemic lupus erythematosus |
| title_full_unstemmed | Editorial Comment to Successful pembrolizumab treatment in a patient with metastatic urothelial carcinoma and underlying overlap syndrome involving systemic sclerosis and systemic lupus erythematosus |
| title_short | Editorial Comment to Successful pembrolizumab treatment in a patient with metastatic urothelial carcinoma and underlying overlap syndrome involving systemic sclerosis and systemic lupus erythematosus |
| title_sort | editorial comment to successful pembrolizumab treatment in a patient with metastatic urothelial carcinoma and underlying overlap syndrome involving systemic sclerosis and systemic lupus erythematosus |
| topic | Editorial Comment |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7469765/ https://www.ncbi.nlm.nih.gov/pubmed/32914069 http://dx.doi.org/10.1002/iju5.12193 |
| work_keys_str_mv | AT hatakeyamashingo editorialcommenttosuccessfulpembrolizumabtreatmentinapatientwithmetastaticurothelialcarcinomaandunderlyingoverlapsyndromeinvolvingsystemicsclerosisandsystemiclupuserythematosus AT ohyamachikara editorialcommenttosuccessfulpembrolizumabtreatmentinapatientwithmetastaticurothelialcarcinomaandunderlyingoverlapsyndromeinvolvingsystemicsclerosisandsystemiclupuserythematosus |